Home » Topics » Science » New compound

New compound
RSS

[68Ga]Ga-ProBOMB2 is a promising new GRPR-imaging PET radiotracer

Oct. 21, 2019

Novel albumin-binding agents for FAP-targeted radionuclide therapy presented

Oct. 18, 2019

Synthesis and characterization of novel N-carboxymethyl-substituted PSMA ligands

Oct. 18, 2019

18F-Labeled PSMA ligand development leads to clinical candidate [18F]siPSMA-14

Oct. 18, 2019

Researchers present YU-253911, a new oxopyrazole antibiotic against Acinetobacter

Oct. 16, 2019

Weak albumin-binding PSMA radioligands for improved prostate cancer therapy

Oct. 16, 2019

Novel PSMA-targeting 177-Lu radiolabeled compounds with outstanding tumor uptake presented

Oct. 15, 2019

Black Diamond Therapeutics describes preclinical activity of mutant EGFR/HER2 inhibitor BDTX-189

Oct. 4, 2019

Discovery of novel small-molecule inhibitor of PWWP1 domain of NSD3 for acute myeloid leukemia

Oct. 3, 2019

Novel near-infrared probe of biliary anatomy for image-guided hepatic surgery

Sep. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...